These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32843482)

  • 21. Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis.
    De Vecchis R; Cesaro A; Ariano C; Giasi A; Cioppa C
    J Clin Med Res; 2017 Jun; 9(6):488-498. PubMed ID: 28496549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral iron supplementation in patients with heart failure: a systematic review and meta-analysis.
    Song Z; Tang M; Tang G; Fu G; Ou D; Yao F; Hou X; Zhang D
    ESC Heart Fail; 2022 Oct; 9(5):2779-2786. PubMed ID: 35758130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
    Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
    Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis.
    Qian C; Wei B; Ding J; Wu H; Wang Y
    Can J Cardiol; 2016 Feb; 32(2):151-9. PubMed ID: 26454467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yoga as Adjunct Therapy for Chronic Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Dutta A; Mooventhan A; Nivethitha L
    Avicenna J Med; 2023 Jul; 13(3):151-162. PubMed ID: 37799183
    [No Abstract]   [Full Text] [Related]  

  • 27. Iron Supplementation Improves Cardiovascular Outcomes in Patients with Heart Failure.
    Zhou X; Xu W; Xu Y; Qian Z
    Am J Med; 2019 Aug; 132(8):955-963. PubMed ID: 30853478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron deficiency in heart failure: Efficacy and safety of intravenous iron therapy.
    Kang CK; Pope M; Lang CC; Kalra PR
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28836730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron deficiency is an independent risk factor of increased myocardial energy expenditure in chronic heart failure patients.
    Lin F; Huang Y; An D; Zhan Q; Wang P; Lai W; Zeng Q; Dong S; Ren H; Xu D
    Ann Palliat Med; 2021 Dec; 10(12):12061-12071. PubMed ID: 35016401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients With Heart Failure: A Meta-Analysis of Randomised Controlled Trials.
    Virk SA; Bennett RG; Chow C; Sanders P; Kalman JM; Thomas S; Kumar S
    Heart Lung Circ; 2019 May; 28(5):707-718. PubMed ID: 30509786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial.
    Yu M; Li S; Li S; Li J; Xu H; Chen K
    Trials; 2018 Jul; 19(1):381. PubMed ID: 30012193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status.
    Comín-Colet J; Enjuanes C; González G; Torrens A; Cladellas M; Meroño O; Ribas N; Ruiz S; Gómez M; Verdú JM; Bruguera J
    Eur J Heart Fail; 2013 Oct; 15(10):1164-72. PubMed ID: 23703106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron substitution in the treatment of chronic heart failure.
    Gstrein C; Meyer M; Anabitarte P
    Swiss Med Wkly; 2017; 147():w14453. PubMed ID: 28695549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.
    Enjuanes C; Klip IT; Bruguera J; Cladellas M; Ponikowski P; Banasiak W; van Veldhuisen DJ; van der Meer P; Jankowska EA; Comín-Colet J
    Int J Cardiol; 2014 Jun; 174(2):268-75. PubMed ID: 24768464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis.
    Awad AK; Abdelgalil MS; Gonnah AR; Mouffokes A; Ahmad U; Awad AK; Elbadawy MA; Roberts DH
    Clin Med (Lond); 2024 May; 24(3):100211. PubMed ID: 38643833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure.
    Clark AL; Johnson M; Fairhurst C; Torgerson D; Cockayne S; Rodgers S; Griffin S; Allgar V; Jones L; Nabb S; Harvey I; Squire I; Murphy J; Greenstone M
    Health Technol Assess; 2015 Sep; 19(75):1-120. PubMed ID: 26393373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Traditional Chinese Medicine Cutaneous Regions Therapy as adjuvant treatment of chronic heart failure: A systematic review and meta-analysis.
    Li M; Li H; Liu H; Lai X; Xing W; Shang J
    Heliyon; 2023 May; 9(5):e16012. PubMed ID: 37206004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
    Anker SD; Kirwan BA; van Veldhuisen DJ; Filippatos G; Comin-Colet J; Ruschitzka F; Lüscher TF; Arutyunov GP; Motro M; Mori C; Roubert B; Pocock SJ; Ponikowski P
    Eur J Heart Fail; 2018 Jan; 20(1):125-133. PubMed ID: 28436136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
    De Vecchis R; Cesaro A; Ariano C
    Minerva Cardioangiol; 2018 Oct; 66(5):659-670. PubMed ID: 28398017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.
    DE Vecchis R; Ariano C
    Minerva Cardioangiol; 2017 Aug; 65(4):427-442. PubMed ID: 27958695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.